News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Press releases 31 Aug 2017 U.S. FDA approves Chemo Group’s benznidazole to treat children with Chagas disease
Press releases 8 Aug 2017 DNDi welcomes Dr Marie-Paule Kieny as new Chair of the Board of Directors with Prof. Marcel Tanner stepping down after ten successful years
Press releases 6 Jul 2017 Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to develop a new treatment for drug-resistant gonorrhea
Press releases 6 Jun 2017 Child-friendly formulation of WHO-recommended HIV treatment now approved by the CDSCO
Press releases 3 May 2017 New open source project engages universities in neglected diseases drug discovery
Press releases 19 Apr 2017 Merck joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases
Press releases 13 Apr 2017 First large-scale survey of Chagas disease in the United States confirms that the “Silent Killer” is a major public health challenge for the country
Press releases 30 Mar 2017 Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Press releases 14 Feb 2017 Study confirms key therapeutic advance for children living with HIV and tuberculosis
Press releases 22 Oct 2016 African eye worm is worse than it looks: new study shows that the disease leads to increased mortality
Press releases 22 Sep 2016 Global Antibiotic Research & Development Partnership receives financial support from Swiss Government
Press releases 14 Jul 2016 “Towards Ending the Neglect?” DNDi releases update on its Paediatric HIV Programme
Press releases 15 Jun 2016 Celgene joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases
Press releases 8 Jun 2016 DNDi, Mundo Sano and Chemo team up to register benznidazole in US and Latin America
